Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro

RT @VinciBiochem: Phosphorylation of AKT and ERK1/2 and mutations of #PIK3CA and #PTEN are predictive of breast cancer cell sensitivity t…

Phosphorylation of AKT and ERK1/2 and mutations of #PIK3CA and #PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro. Everolimus is the hydroxyethyl derivative of sirolimus and a strong inhibitor of mammalian target of.. @Unipisa

Phosphorylation of AKT & ERK1/2 and Mutations of PIK3CA and PTEN Are Predictive of #BreastCancer Cell Sensitivity to Everolimus In Vitro @Unipisa https://t.co/VXbtyzhfBJ